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Summary
 Aim Use of Rotterdam applicators was analysed for the purpose of ascertaining the 
average dose to the spinal cord at the point of greatest load.
 Materials/Methods 20 procedures carried out on patients treated in the brachytherapy department 
were evaluated. Rotterdam nosopharynx applicators were positioned and local-
ised according to the “box technique”. The radiographs were used to reconstruct 
the applicator in PLATO NPS version 14.1.3 treatment planning system. The po-
sition of spinal cord points were inserted according to the radiographs. The high-
est-loaded points were chosen to analyze.
 Results Points were localized (along the cord) to within an average accuracy of 0.52mm. 
A comparison of doses in the cord at these points was carried out and the average 
dose using geometrical optimization (on distance) was 19.7% of the reference 
dose while without optimisation the average was 18.7% of the reference dose.
 Conclusions From the study undertaken, it appears that the calculated doses in the spinal 
cord, at the points of greatest load, are as described in the published data. The 
Rotterdam applicator may be used equally for radical treatment and for locally 
increasing the dose (boost) because of an acceptable spinal cord dose.
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BACKGROUND
Radiotherapy of nasopharyngeal cancer is com-
plicated by the nearness of critical organs. One of 
the main critical organs in this area is the spinal 
cord. Brachytherapy is a safe method for delivering 
high doses to the target. The miniaturised sources 
used in HDR brachytherapy reconstruction based 
on CT images, ability to optimize the dose distri-
butions, ensures that the method may be an alter-
native for the treatment of patients treated with 
external beam therapy. Attempts to estimate dose 
in the spinal cords of patients treated with brachy-
therapy in the nasopharynx are valid.
AIM
Use of Rotterdam applicators was analysed for the 
purpose of ascertaining the average dose to the 
spinal cord at the point of greatest load.
MATERIALS AND METHODS
The use of Rotterdam applicator was analysed for 
the patients treated between July 2000, and April 
2003. A microSelectron HDR (Nucletron) ma-
chine with an Ir 192 source was used. Treatments 
were carried out on 16 patients: 6 women and 10 
men. Among these patients a total of 20 proce-
dures were performed: one patient underwent ap-
plicator insertion three times, two patients under-
went two such implantations and the remaining 
thirteen patients only once. Altogether 129 ther-
apeutic fractions were delivered. The total dose 
used in these patients ranged from 6Gy to 51Gy in 
dose fraction of 3Gy daily: three patients received 
51Gy, two received 30Gy, two 15Gy, three 6Gy, and 
the remainder received 42Gy, 24Gy, 21Gy,18Gy, 
12Gy and 9Gy. Procedures were carried out by a 
laryngologist who ﬁ xed silicon applicators in con-
tact with nasopharynx. The Rotterdam applicator 
set consisted of a contact applicator, 2 catheters 
into which the iridium source was loaded, and sil-
icon spray to ease ﬁ tting of the catheters into the 
applicator (Figure 1).
The silicon contact applicator remained in na-
sopharynx from 2 to 5 days, depending on clinical 
indications and on the tolerance of the patient. 
X-ray imaging was repeated during the course of 
treatment, in the case of several selected patients. 
Implants were stable meaning that daily reposi-
tioning of applicators was unnecessary.
Geometrical reconstruction of applicator posi-
tion was carried out using the “box” technique 
on the basis of two orthogonal X-ray images, with 
localisation markers (Figure 2). Positioning of 
applicator was also carried out on the basis of 
CT images.
Dose distribution was calculated with a PLATO 
BPS (version 14.1.3) treatment planning system.
Positioning of catheters at several points along the 
spinal cord was reconstructed. On the basis of CT 
images, the areas irradiated and active length were 
deﬁ ned. The reference dose was the average dose 
at reference points positioned within 10mm of the 
source axis for each of the catheters [1]. Two treat-
ment plans were analysed for each application: a 
plan in which a geometric distance optimisation 
algorithm had been used and a plan without op-
timisation in which the dwell time in all dwell po-
sitions was the same. The optimisation algorithm 
changed the dwell time at each position, evening 
out the dose value at the reference points in or-
der to attain the planned reference dose.
RESULTS
On the basis of X-ray images, points on along the 
spinal cord were located with an average accura-
cy of 0.52mm (ranging from 0.1 to 1.5mm). The 
active length ranged from 20 to 70mm the aver-
age value was 45.8mm.
Average spinal cord dose values were compared 
for the two types of treatment plan. For optimised 
plans, the average load on the cord amounted to 
19.7% (±6.3%) of the reference dose. For treat-
ment plans without optimisation the average load 
amounted to 18.7% (±6.1%).
From the results obtained it may be calculated 
that, assuming a fractional dose of 3Gy at the 
Figure 1. Prepared kit for the insertion of a Rotterdam 
applicator.
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reference points, the average fractional dose in 
the spinal cord amounted to 0.59Gy (for opti-
mised plans). On the basis of the linear-quad-
ratic model, the EQD2 dose was calculated us-
ing the formula:
EQD2 = D 
d + a/b
                 2 + a/b
where D is the total dose and d is a fraction 
dose.
In the case of the patient who received a ther-
apeutic dose of 51Gy (17 fractions at 3Gy dai-
ly), the balanced dose EQD2 in the spinal cord 
amounted to 7.2Gy (the value was calculated for: 
a/b=3Gy [2].
DISCUSSION
Our experience of HDR brachytherapy using 
Rotterdam applicator shows that it is a treatment 
well tolerated by patients. Insertion of the applica-
tor to the nasopharyngeal cavity was not a compli-
cated procedure. Once the applicator was ﬁ xed into 
the therapeutic position it was stable, ensuring that 
the source could follow the same course repeated-
ly through a series of days of treatment. The treat-
ment plan (and dose distribution plans) was accept-
ed before the ﬁ rst treatment fraction and realized 
during the course of following days of therapy.
From an analysis of treatment plans it appears that 
the dose delivered, to the points of the cord clos-
est to the positions of the source, amounted to 
an average of 19.2% of the prescribed dose. Dose 
gradients within the area of the spinal cord are 
very steep and therefore parts of the cord receive 
markedly lower doses. Because the fraction dose 
in the cord was low, the equivalent EQD2 dose was 
lower than the physical dose. This showed that 
doses received by the cord during treatments us-
ing the described method are safe. The results ob-
tained are in agreement with those of Levendag 
and co-workers, who found that load on the spinal 
cord was around 20% of the therapeutic dose [1]. 
For every patient, individual activity length were 
deﬁ ned. No correlation was discovered, howev-
er, between the active length and dose values in 
the cord. A small standard deviation in the val-
ues of analysed parameters suggests that the load 
to the spinal cord during the described therapy 
was comparable in each case.
Our analysis of spinal cord doses showed a small 
difference between optimised and non-optimized 
treatment plans. The differences, according to 
student’s t test for paired data, were not statisti-
cally signiﬁ cant. For the majority of patients, dose 
distribution without optimization may be used. 
The optimization algorithm increases dwell time 
at peripheral treatment position, increasing the 
“contact ” dose at the surfaces of the mucousal 
Figure 2. AP and LR X-ray image with localisation markers.
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membranes, which may be a cause of compli-
cations.
CONCLUSIONS
We conclude that myelopathy risks during 
HDR brachytherapy of the nasopharynx, using 
Rotterdam applicator, is acceptable. Dose ab-
sorption in small volumes of the cord amounts 
to an average of 19.2% of the reference dose. 
The position of the applicator is ﬁ xed for the 
remainder of subsequent fractions, ensuring re-
producibility of dose distribution. Treatment is 
well tolerated by patients. The described meth-
od of treatment may be used both as a radical 
treatment in the case of recurrence and for lo-
calized dosage increase (boost) in the radical ra-
diotherapy of primary malignant tumours of the 
nasopharynx [3].
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